AbbVie AS
Aksjeselskap (AS) · Fornebu, Norway · LEI 549300L8C3XRJFYK9H81
LEI lapsed
Summary
AbbVie AS is registered in Norway and entered in the “Register of Business Enterprises (Foretaksregisteret)” under number 998 085 497. Its legal form is Aksjeselskap (AS) – limited company (Norway). According to GLEIF, its ultimate parent is ABBVIE INC. (United States), which is also its direct parent. That group has 64 subsidiaries with LEIs in 37 countries, 1 of them in Norway. The LEI was first issued on 6 Jun 2018 and the record was last updated on 9 Aug 2023. It has lapsed: renewal was due by 5 Jun 2019. AssetCensus found 3 data-quality notes for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 5 Jun 2019 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
- The ultimate-parent link rests on accounts for the period ending 31 Mar 2018, more than 24 months before this data release. The group may have changed since.
- The ultimate-parent relationship record was not renewed; it was last updated on 9 Aug 2023.
Company details
| Legal form | Aksjeselskap (AS) limited company (Norway) |
|---|---|
| Register | Register of Business Enterprises (Foretaksregisteret) · Register website |
| Registration number | 998 085 497 |
| Registration authority | The Brønnøysund Register Centre |
| Jurisdiction | Norway |
| Registered address | Martin Linges Vei 25, 1364 Fornebu, Norway |
| Category | company or other legal entity |
| Status | active |
| LEI | 549300L8C3XRJFYK9H81 |
| LEI status | lapsed |
| LEI first issued | 6 Jun 2018 |
| LEI record last updated | 9 Aug 2023 |
| Next LEI renewal | 5 Jun 2019 |
| Corroboration of the LEI record | fully corroborated |
Group membership
AbbVie AS this entity
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | ABBVIE INC. | ABBVIE INC. |
| Accounting period | 1 Apr 2017 to 31 Mar 2018 | 1 Apr 2017 to 31 Mar 2018 |
| Evidence | supporting documents | supporting documents |
| Corroboration | supplied by the entity only | supplied by the entity only |
| Relationship start | 5 Jun 2018 | 5 Jun 2018 |
| Recorded at GLEIF since | 6 Jun 2018 | 6 Jun 2018 |
| Last updated | 9 Aug 2023 | 9 Aug 2023 |
| Record status | not renewed | not renewed |
Other subsidiaries of the same direct parent (59)
- AbbVie A/S Denmark lapsed
- AbbVie AG Switzerland lapsed
- AbbVie B.V. Netherlands lapsed
- AbbVie Bahamas Ltd. Bahamas lapsed
- AbbVie Biopharmaceuticals GmbH Switzerland
- ABBVIE BIOTECHNOLOGY LTD Bermuda
- AbbVie Central Finance B.V. Netherlands
- AbbVie Corporation Canada
- ABBVIE D.O.O. Slovenia lapsed
- AbbVie Deutschland GmbH And Co. KG Germany lapsed
- Abbvie Endocrine Inc. United States lapsed
- AbbVie Enterprises B.V. Netherlands
Other names
- WCA Pharmaceuticals AS · previous name